Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with a drug called fenofibrate, which
is a PPAR-alpha agonist and controls how the heart metabolizes fats, will reverse the
age-related decline in cardiac fat metabolism and mechanical function.